Bio-Techne (TECH) news
Recent news
German Federal Cartel Office approves the takeover of Bio-Techne by Merck KGaA (Darmstadt)
The German Federal Cartel Office has approved Merck KGaA’s (Darmstadt) proposed acquisition of Bio-Techne Corporation, a U.S.-based global provider of life science tools and analytical technologies. The approval marks a key regulatory milestone for the transaction, which is valued at approximately…
AInvest Wire · Aug 17, 2026Bio-Techne 4Q net sales $321.2M, est. $314.6M
AInvest Wire · Aug 12, 2026Bio-Techne 4Q adj EPS 52c, est. 52c
AInvest Wire · Aug 12, 2026BIO-TECHNE CORP: Evercore ISI cuts to in line from outperform
Evercore ISI has downgraded Bio-Techne Corp (TECH) from "Outperform" to "In Line," while adjusting its price target to $62 from $68, reflecting a more cautious outlook on the biotechnology company’s near-term prospects. The move follows recent analyst activity that has seen mixed signals, with…
AInvest Wire · Jul 6, 2026Bio-Techne Corp: Benchmark cuts to hold from buy
Bio-Techne Corp. (NASDAQ: TECH) has seen several recent downgrades from analysts, reflecting shifting sentiment following the announcement of its proposed acquisition by Merck KGaA. Leerink Partners downgraded the stock from "Strong-Buy" to "Hold" in a report issued on June 26 . This move aligns…
AInvest Wire · Jun 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.